Inflammatory bowel disease
Upadacitinib demonstrates one-year effectiveness in refractory perianal Crohn’s disease
3D imaging and Crohn’s disease strictures: practice perspectives
Gut biomarkers identified to improve detection and targeted treatment of GI disorders
Ulcerative colitis becomes fourth approved indication for risankizumab in Europe
The benefits of transitioning to biosimilar adalimumab in Crohn’s disease
New protocol for IBD referral triage reduces diagnostic delays, say researchers
Green light from MHRA and NICE for use of etrasimod in ulcerative colitis
Study redefines early treatment of Crohn’s disease and improves outcomes
Etrasimod positive opinion for ulcerative colitis upgraded to approval in EU
Positive CHMP opinion for etrasimod in adults and older adolescents with ulcerative colitis
Risankizumab surpasses ustekinumab when head to head in Crohn‘s disease
Anti-IL17 peptide shows high clinical efficacy for immune-related inflammatory diseases
New IBD awareness campaign encourages innovative treatment access
Faecal transplantation increases remission in ulcerative colitis
Endocan useful marker for disease extent in ulcerative colitis